SCHEMBL7776569

SCHEMBL7776569

Cc1nc2cnccc2n1-c1ccc(Cn2c(=O)sc3cc(C(C)C)ccc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.42
PTAFR P25105 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7776564 0.89
SCHEMBL7774882 0.88 BRD4 (0.45)
SCHEMBL7774780 0.88 MEN1 (0.44)
SCHEMBL7774503 0.87 BRD4 (0.39)
SCHEMBL7776415 0.85 POLB (0.47) SMN1; SMN2
SCHEMBL6705396 0.85 L3MBTL1 (0.51) SMN1; SMN2
SCHEMBL7776556 0.85
SCHEMBL7770183 0.85
SCHEMBL7770171 0.84 BRD4 (0.44)
SCHEMBL7776541 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125936-A2 Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases Pfizer Products Inc. (US) 2001-08-22 EP claimed
US-6242461-B1 Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases PFIZER INC. 2001-06-05 US claimed
EP-1125936-A2 Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases Pfizer Products Inc. (US) 2001-08-22 EP disclosed
US-6242461-B1 Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases PFIZER INC. 2001-06-05 US disclosed